Advances in the understanding of gut hormone physiology particularly their role in appetite regulation, metabolism, and glucose homeostasis - have driven the development of glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) as effective and safe treatments for type 2 diabetes (T2D) and obesity
Weeks 58: Momentum builds By weeks 58, many people notice a clearer routine of the tirzepatide timeline: smaller plates, steadier energy between meals, and less food noise. If youre tolerating 5 mg, your dose may rise by 2.5 mg after at least four weeks on your current dose
Rural counties in West and East Tennessee have limited endocrinology and obesity medicine specialists
Eur Respir J (2020) 55:2000547
Research has shown that GLP-1s effectively reduce blood glucose in people with type 2 diabetes
Protein and fibre at each meal: These nutrients enhance satiety and reduce cravings